The faculty of language: what is it, who has it, and how did it evolve?
We argue that an understanding of the faculty of language requires substantial interdisciplinary
cooperation. We suggest how current developments in linguistics can be profitably …
cooperation. We suggest how current developments in linguistics can be profitably …
“Drinking in the dark”(DID) procedures: a model of binge-like ethanol drinking in non-dependent mice
TE Thiele, M Navarro - Alcohol, 2014 - Elsevier
This review provides an overview of an animal model of binge-like ethanol drinking that has
come to be called “drinking in the dark” (DID), a procedure that promotes high levels of …
come to be called “drinking in the dark” (DID), a procedure that promotes high levels of …
[HTML][HTML] Nexus between green finance and climate change mitigation in N-11 and BRICS countries: empirical estimation through difference in differences (DID) …
Green finance is inextricably linked to investment risk, particularly in emerging and
developing economies (EMDE). This study uses the difference in differences (DID) method to …
developing economies (EMDE). This study uses the difference in differences (DID) method to …
Patterns of dystonia (" IDI" and" DID-") in response to l-dopa therapy for Parkinson's disease.
MD Muenter, NS Sharpless, GM Tyce… - Mayo Clinic …, 1977 - europepmc.org
… Dystonia occurs in the DID-response when the concentration of dopa in plasma passes …
low, in the DID-response by keeping it high. It is postulated that in the DID response postsynaptic …
low, in the DID-response by keeping it high. It is postulated that in the DID response postsynaptic …
The economic burden of depression in the United States: how did it change between 1990 and 2000?
PE Greenberg, RC Kessler, HG Birnbaum… - Journal of clinical …, 2003 - psychiatrist.com
Background: The economic burden of depression was estimated to be $43.7 billion in 1990.
A subsequent study reported a cost burden of $52.9 billion using revised prevalence data …
A subsequent study reported a cost burden of $52.9 billion using revised prevalence data …
[PDF][PDF] Metabolic reprogramming: a cancer hallmark even warburg did not anticipate
PS Ward, CB Thompson - Cancer cell, 2012 - cell.com
Cancer metabolism has long been equated with aerobic glycolysis, seen by early biochemists
as primitive and inefficient. Despite these early beliefs, the metabolic signatures of cancer …
as primitive and inefficient. Despite these early beliefs, the metabolic signatures of cancer …
Did securitization lead to lax screening? Evidence from subprime loans
A central question surrounding the current subprime crisis is whether the securitization
process reduced the incentives of financial intermediaries to carefully screen borrowers. We …
process reduced the incentives of financial intermediaries to carefully screen borrowers. We …
[PDF][PDF] How did economists get it so wrong?
P Krugman - New York Times, 2009 - econ.ucdavis.edu
… But he did challenge the notion that free-market economies … It’s important to understand
that Keynes did much more than … did any good, but they didn’t believe it did any harm, either.) …
that Keynes did much more than … did any good, but they didn’t believe it did any harm, either.) …
[PDF][PDF] Students whose parents did not go to college: Postsecondary access, persistence, and attainment
SP Choy - 2001 - nces.ed.gov
… , graduates whose parents did not attend college were about … a bachelor’s degree, did not
appear to have an advantage … and high school coursetaking did not independently affect the …
appear to have an advantage … and high school coursetaking did not independently affect the …
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
C Ikonomidou, L Turski - The Lancet Neurology, 2002 - thelancet.com
Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists (competitive receptor antagonists,
ion channel blockers, and glycine antagonists)—such as selfotel, aptiganel, eliprodil, …
ion channel blockers, and glycine antagonists)—such as selfotel, aptiganel, eliprodil, …